Stephan A. Carey, DVM, PhD, DACVIM (SAIM): No relevant disclosure to display
Presentation Description / Summary: Lymphoplasmacytic rhinitis is a common nasal disease of cats with unknown etiology. Treatment options are limited, and the disease is considered incurable. Given the inherent radiosensitivity of lymphocytes to ionizing radiation, low-dose radiation therapy was considered as a treatment option for cats with refractory disease. In this session we will review the components of a comprehensive diagnostic approach to feline chronic rhinitis, discuss a rational management plan for feline chronic rhinitis based on addressing clinical signs and morphologic alterations in the nasal mucosa, and describe the potential role for low-dose radiation therapy as a treatment option for feline chronic rhinitis. Objectives of the study were to determine whether the use of low-dose radiation therapy causes a reduction in owner-reported clinical signs of chronic rhinitis, and to determine whether low-dose radiation therapy can be administered to patients without the development of short and long-term radiation therapy associated adverse effects. A prospective clinical trial recruited 11 cats with chronic lymphoplasmacytic rhinitis defined via clinical history, CT, rhinoscopy, tissue culture, and histopathology. Cats received 2 Gy/day on 3 consecutive days. Clinical efficacy was evaluated via owner-reported assessment using a severity of nasal inflammatory disease (SNIFLD) questionnaire modified for use in feline chronic rhinitis. Adverse effects were documented via examinations following each radiation treatment, owner follow-up, and recheck examinations at 1, 3, 6 and 12 months post treatment. All 11 cats successfully completed the treatment protocol and were available for 12-month follow-up. No cats exhibited acute adverse effects, and 1 cat developed subtle leukotrichia approximately 6-months post treatment. Ten of 11 cats showed improvement of owner-reported quality of life scores and clinical signs at 1- and 3-months post treatment. In most cats, clinical signs returned to pre-treatment baseline by 6-months post treatment. Radiation therapy is a potentially safe and effective modality for feline chronic rhinitis that warrants further investigation.
Learning Objectives:
Participants will be able to describe a comprehensive diagnostic approach for feline chronic rhinitis, including the histologic features that distinguish chronic rhinitis from chronic-active and acute rhinitis.
Participants will be able to create a rational management plan for chronic rhinitis based on management of clinical signs and addressing morphologic alterations in the nasal mucosa.
Participants will be able to predict expected clinical responses and potential adverse effects experienced by cats treated with low-dose radiation therapy for the management of refractory chronic rhinitis.